« Previous
Next »
Techniques in Vascular & Interventional Radiology
Volume 10, Issue 1
, Pages 12-29
, March 2007
Technical Aspects of Radioembolization with 90Y Microspheres
References
- . Hepatocellular carcinoma and hepatitis C in the United States. Hepatology. 2002;36(suppl 1):S74–S83
- Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10–30
- Percutaneous radiofrequency ablation of small hepatocellular carcinoma: Long-term results. Eur Radiol. 2001;11:914–921
- . Cryotherapy for neuroendocrine liver metastases. Semin Surg Oncol. 1998;14:175–183
- . Chemical ablation of hepatocellular carcinoma. J Vasc Interv Radiol. 2002;13:S245–S252
- Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 2002;35:1164–1171
- Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomised controlled trial. Lancet. 2002;359:1734–1739
- Particle embolization for hepatocellular carcinoma. J Vasc Interv Radiol. 1998;9:822–828
- Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys. 1995;31:1237–1248
- Radiation hepatitis. Am J Roentgenol Radium Ther Nucl Med. 1965;93:200–208
- . Selective internal radiation therapy (SIRT) with 90Yttrium microspheres for extensive colorectal liver metastases. Hepatogastroenterology. 2001;48:333–337
- Yttrium-90 microspheres for the treatment of hepatocellular carcinoma. Gastroenterology. 2004;127(suppl 1):S194–S205
- . Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: Interim safety and survival data on 65 patients. Liver Transpl. 2004;10(suppl 1):S107–S110
- Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol. 2001;12:1711–1720
- Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol. 2004;88:78–85
- Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): Safety, tumor response, and survival. J Vasc Interv Radiol. 2005;16:1627–1639
- Radioembolization with (90)y microspheres: Angiographic and technical considerations. Cardiovasc Intervent Radiol. 2007;30:571–592
- Angiographic considerations in patients undergoing liver-directed therapy. J Vasc Interv Radiol. 2005;16:911–935
- Tolerance of the liver to the effects of Yttrium-90 radiation. Int J Radiat Oncol Biol Phys. 1990;18:619–623
- Yttrium-90 microsphere therapy for hepatic malignancy: Devices, indications, technical considerations, and potential complications. Radiographics. 2005;25(suppl 1):S41–S55
- . Radioembolization with 90Yttrium microspheres: A state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: Part 1: Technical and methodologic considerations. J Vasc Interv Radiol. 2006;17:1251–1278
- . Selective internal radiation therapy with 90Yttrium microspheres for extensive colorectal liver metastases. J Gastrointest Surg. 2001;5:294–302
- Variant hepatic arterial anatomy revisited: Digital subtraction angiography performed in 600 patients. Radiology. 2002;224:542–547
- Right gastric artery embolization prior to treatment with yttrium-90 microspheres. Cardiovasc Intervent Radiol. 2007;30:98–103
- Radiation-induced ulceration of the stomach secondary to hepatic embolization with radioactive yttrium microspheres in the treatment of metastatic colon cancer. J Gastroenterol Hepatol. 2004;19:347–349
- Treatment of unresectable metastatic colorectal carcinoma to the liver with intrahepatic Y-90 microspheres: A dose-ranging study. World J Nuc Med. 2003;2:216–225
- Gastrointestinal complications associated with hepatic arterial Yttrium-90 microsphere therapy. J Vasc Interv Radiol. 2007;18:553–561
- Giant gastric ulcer: Its natural history and outcome in the H2RA era. Am J Gastroenterol. 1999;94:3478–3486
- . Gastrointestinal: Giant gastric ulcers. J Gastroenterol Hepatol. 2001;16:573
- . Cutaneous complications of hepatic chemoembolization via extrahepatic collaterals. J Vasc Interv Radiol. 1999;10:1351–1356
- Yttrium-90 microspheres: Radiation therapy for unresectable liver cancer. J Vasc Interv Radiol. 2002;13:S223–S229
- Recognizing extrahepatic collateral vessels that supply hepatocellular carcinoma to avoid complications of transcatheter arterial chemoembolization. Radiographics. 2005;25(suppl 1):S25–S39
- The effect of catheter-directed CT angiography on Yttrium-90 radioembolization treatment of hepatocellular carcinoma. J Vasc Interv Radiol. 2005;16:1085–1091
- Use of Yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis. J Vasc Interv Radiol. 2004;15:335–345
- Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: Preliminary results. J Vasc Interv Radiol. 2005;16:937–945
Disclosure of potential conflicts of interest: RS has received research grant support and is a consultant for MDS Nordion. RM has received research grant support from Sirtex Medical. None of the other authors have disclosed a potential conflict of interest.
PII: S1089-2516(07)00077-7
doi: 10.1053/j.tvir.2007.08.001
© 2007 Elsevier Inc. All rights reserved.
« Previous
Next »
Techniques in Vascular & Interventional Radiology
Volume 10, Issue 1
, Pages 12-29
, March 2007
